Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Early research (Phase 1)Study completedNCT04870840
What this trial is testing

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT04823468
What this trial is testing

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNutritional Support
Jinsheng Hong 236
Testing effectiveness (Phase 2)UnknownNCT05229315
What this trial is testing

PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaT2-3N0 or T1-2N1EBV-DNA≤4000 Copy/ml
XIANG YANQUN 45
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Looking for participantsNCT06349889
What this trial is testing

Adebrelimab and Chemoradiotherapy in High-risk LANPC

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT00062387
What this trial is testing

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT02123511
What this trial is testing

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Who this might be right for
MucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more
Mayo Clinic 34
Testing effectiveness (Phase 2)Study completedNCT00376987
What this trial is testing

Zinc Supplements in Lowering Cadmium Levels in Smokers

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Wake Forest University Health Sciences 61
Large-scale testing (Phase 3)Looking for participantsNCT07327216
What this trial is testing

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Affiliated Hospital of Guangdong Medical University 180
Testing effectiveness (Phase 2)UnknownNCT00004164
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01816984
What this trial is testing

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
University of Chicago 12
Testing effectiveness (Phase 2)UnknownNCT04446663
What this trial is testing

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
First People's Hospital of Foshan 50
Testing effectiveness (Phase 2)UnknownNCT00816816
What this trial is testing

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 64
Large-scale testing (Phase 3)WithdrawnNCT01545687
What this trial is testing

CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy

Who this might be right for
Head and Neck CancerOral Complications of Radiation TherapyPain+1 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Study completedNCT00021333
What this trial is testing

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Fox Chase Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT00022217
What this trial is testing

Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical
Testing effectiveness (Phase 2)UnknownNCT01612286
What this trial is testing

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05198531
What this trial is testing

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent / Metastatic Nasopharyngeal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Next Page